title: Reduction of hydroxamic acids to the corresponding amides catalyzed by rabbit blood.
abstract: 1. The hydroxamic acids N-hydroxyphenacetin and N-hydroxy-2-acetylaminofluorene were reduced to the corresponding amides, phenacetin and 2-acetylaminofluorene respectively by rabbit blood supplemented with both NAD(P)H and FAD. These reducing activities were found in erythrocytes but not in plasma, and were sensitive to inhibition by carbon monoxide and oxygen. When blood or erythrocytes were boiled, these activities were not abolished. 2. Haemoproteins such as haemoglobin and catalase exhibited the reductase activity in the presence of both NAD(P)H and FAD under anaerobic conditions. The activity was not abolished when the haemoproteins were boiled. 3. Haematin showed a significant reducing activity in the presence of these cofactors. The activity of haematin was also observed with the photochemically reduced form of FAD. 4. The reduction system in blood was composed of NAD(P)H, FAD and haemoglobin. Reduction appears to proceed in two steps, i.e. the reduction of FAD by NADH or NADPH, followed by the non-enzymatic reduction of the hydroxamic acids to the amides by reduced FAD, catalyzed by the haem group of haemoglobin in rabbit erythrocytes.
authors.affiliation: Institute of Pharmaceutical Science, Hiroshima University School of Medicine, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Sugihara
authors.forename: S
authors.initials: S
authors.lastname: Kitamura
authors.forename: S
authors.initials: S
authors.lastname: Ohta
authors.forename: K
authors.initials: K
authors.lastname: Tatsumi
mesh_terms: D015073:2-Acetylaminofluorene / Q000097:blood / Q000737:chemistry / Q000378:metabolism*; D000818:Animals; D001769:Blood; D002248:Carbon Monoxide / Q000494:pharmacology; D002374:Catalase / Q000378:metabolism; D004912:Erythrocytes / Q000201:enzymology / Q000378:metabolism; D005182:Flavin-Adenine Dinucleotide / Q000097:blood / Q000378:metabolism; D006454:Hemoglobins / Q000378:metabolism; D006877:Hydroxamic Acids / Q000378:metabolism*; D007700:Kinetics; D008297:Male; D008954:Models, Biological; D009249:NADP / Q000097:blood / Q000378:metabolism; D009536:Niacinamide / Q000031:analogs & derivatives* / Q000378:metabolism; D010100:Oxygen / Q000494:pharmacology; D010615:Phenacetin / Q000031:analogs & derivatives* / Q000097:blood / Q000737:chemistry / Q000378:metabolism*; D011817:Rabbits; D051381:Rats; D012457:Salicylamides / Q000378:metabolism; D013997:Time Factors
chemical_list: D006454:Hemoglobins; D006877:Hydroxamic Acids; D012457:Salicylamides; D005182:Flavin-Adenine Dinucleotide; C008068:N-hydroxyphenacetin; D009536:Niacinamide; D009249:NADP; D002248:Carbon Monoxide; C005703:salicylhydroxamic acid; D015073:2-Acetylaminofluorene; D002374:Catalase; D010615:Phenacetin; D010100:Oxygen; C020427:nicotinohydroxamic acid